自适应调强放疗对鼻咽癌患者中性粒细胞与淋巴细胞比值的影响
该回顾性研究纳入2014年1月至2015年12月的122例鼻咽癌患者,采用倾向性评分1:1匹配比较自适应放疗(ART)与非ART组。结果显示ART组放疗期间ΔNLR、ΔCLC、ΔCPC、ΔCNC变化显著不同,腮腺、皮肤、口腔急性放射损伤及体重下降也更轻。多因素分析中ART是ΔNLR、ΔCLC和ΔCPC的影响因素,T1-2期患者获益更大。
要点
- ART组放疗期间ΔNLR、ΔCLC、ΔCPC、ΔCNC变化与非ART组存在显著差异。
- ART组腮腺、皮肤、口腔急性放射损伤及体重下降均显著低于非ART组。
- ART是ΔNLR、ΔCLC和ΔCPC的影响因素,T1-2期患者ΔCLC获益更明显。
核心结论
- ART可改善鼻咽癌患者放疗期间ΔNLR、ΔCLC和ΔCPC的变化,并减少皮肤、腮腺副作用及体重下降。
- T1-2期鼻咽癌患者从ART中获益更大。
研究设计与样本
- 回顾性分析2014年1月至2015年12月的122例鼻咽癌患者。
- 采用倾向性评分匹配法以1:1比例匹配两组患者。
- 数据分析采用Kaplan-Meier法、log-rank检验、回归分析和配对t检验。
主要发现
- ART组与非ART组放疗期间ΔNLR(P=0.002)、ΔCLC(P<0.001)、ΔCPC(P=0.036)和ΔCNC差异显著。
- 两组腮腺急性放射损伤(P<0.001)、皮肤(P<0.001)、口腔结构(P<0.001)、Δweight(kg)(P=0.025)和Δweight(%)(P=0.030)差异显著。
- 单因素和多因素分析显示ART(R=0.531,P=0.004)、皮肤相关副作用(R=0.328,P=0.020)和临床分期(R=-0.689,P<0.001)是ΔNLR的影响因素。
- ART是ΔCLC(R=2.108,P<0.001)的影响因素,也是ΔCPC的唯一影响因素(R=0.121,P=0.035)。
- 亚组分析显示T1-2N0-3期患者中ART组ΔCLC高于非ART组(P<0.001,P=0.003,P=0.003)。
临床怎么用
- 对鼻咽癌患者,尤其是T1-2期,可考虑采用ART以减轻放疗期间血液学指标变化及皮肤、腮腺副作用和体重下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Nutritional status and haematological parameters are related to the prognosis of patients treated with radiotherapy, but the correlation between adaptive radiotherapy (ART) and haematological indicators has never been reported. This study explores the influence of ART on the change in haematological indicators and provides a theoretical basis for the use of ART in patients with nasopharyngeal carcinoma (NPC). PATIENTS AND METHODS: We retrospectively analysed 122 patients with NPC from January 2014 to December 2015. Patients in two treatment groups were matched using the propensity score matching method at a ratio of 1:1. The data were analysed with the Kaplan-Meier method, log-rank tests, regression analyses and paired t tests. RESULTS: Significant differences were detected for changes in the neutrophil-to-lymphocyte ratio (ΔNLR), circulating lymphocyte count (ΔCLC), circulating platelet count (ΔCPC), and circulating neutrophil granulocyte count (ΔCNC) during radiotherapy (P = 0.002, P < 0.001, and P = 0.036, respectively) between the ART and non-ART groups. Differences in acute radiation injury to the parotid glands (PGs) (P < 0.001), skin (P < 0.001), and oral structures (P < 0.001), Δweight (kg) (P = 0.025), and Δweight (%) (P = 0.030) were also significant between the two groups. According to univariate and multivariate analyses, ART (R = 0.531, P = 0.004), skin-related side effects (R = 0.328, P = 0.020), and clinical stage (R = -0.689, P < 0.001) are influencing factors for the ΔNLR in patients. ART is also the influencing factor for the ΔCLC (R = 2.108, P < 0.001) and the only factor affecting the ΔCPC (R = 0.121, P = 0.035). Based on subgroup analyses, for stage T1-2N0-3 disease, ΔCLC was higher in patients in the ART group than in patients in the non-ART group (P < 0.001, P = 0.003, and P = 0.003). CONCLUSION: ART ameliorates changes in haematological indexes (ΔNLR, ΔCLC, and ΔCPC) and reduces side effects to the skin and PGs and weight loss during radiotherapy in patients with NPC, and patients with stage T1-2 disease experience a greater benefit.
引用
- Han N, Lyu X, Li G, et al. Impact of adaptive intensity-modulated radiotherapy on the neutrophil-to-lymphocyte ratio in patients with nasopharyngeal carcinoma. Radiat Oncol. 2019. PMID: 31438994. doi:10.1186/s13014-019-1350-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。